Evidence map›Paper›PMID 36319968›Full record

Trial reportBMC cancer2022

The diagnostic and prognostic value of radiomics and deep learning technologies for patients with solid pulmonary nodules in chest CT images.

Rui Zhang, Ying Wei, Feng Shi, Jing Ren, Qing Zhou, Weimin Li, Bojiang Chen

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Non-Invasive Procedure in Differential Diagnosis of Sarcoidosis and Tuberculosis Lymph Nodes:  Radiomic Model of 18F-FDG PET-CT.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Quantitative Analysis of TP53-Related Lung Cancer Based on Radiomics.International journal of general medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rui Zhang *Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, 37 GuoXue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, People's Republic of China.
Ying Wei *Department of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Feng ShiDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Jing RenDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, 37 GuoXue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, People's Republic of China.
Qing ZhouDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, China.
Weimin LiDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, 37 GuoXue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, People's Republic of China. weimin003@163.com.
Bojiang ChenDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, 37 GuoXue Alley, Wuhou District, Chengdu, Sichuan Province, 610041, People's Republic of China. cjhcbj@gmail.com.
Sichuan University · CNUnited Imaging Healthcare (China) · CN

Funding

Interdisciplinary Innovation Project of "135 Project" of West China Hospital of Sichuan University ZYJC21028Key R & D project of Sichuan Provincial Department of Science and Technology 2021YFS0072
6 · The paper itself

Abstract

backgroundSolid pulmonary nodules are different from subsolid nodules and the diagnosis is much more challenging. We intended to evaluate the diagnostic and prognostic value of radiomics and deep learning technologies for solid pulmonary nodules.

methodsRetrospectively enroll patients with pathologically-confirmed solid pulmonary nodules and collect clinical data. Obtain pre-treatment high-resolution thoracic CT and manually delineate the nodule in 3D. Then, all patients were randomly divided into training and testing sets at a ratio of 7:3, and convolutional neural networks (CNN) models and random forest (RF) models were established. Survival analyses were performed for patients with solid adenocarcinomas.

resultsTotally 720 solid pulmonary nodules were enrolled, 348 benign and 372 malignant. The CNN model with clinical features achieved the highest AUC [0.819, 95% confidence interval (CI): 0.760-0.877] with a sensitivity of 0.778, specificity of 0.788 and accuracy of 0.783. No significant differences were observed between the CNN and radiomics models. There were 295 solid adenocarcinomas in survival analysis. Different disease-free survival was observed between the low-risk and high-risk groups divided according to the radiomics Rad-score. However, the groups based on deep learning signatures showed similar survival. Cox regression analysis indicated that the radiomics Rad-score (hazard ratio: 5.08, 95% CI: 2.61-9.90) was an independent predictor of recurrence.

conclusionsThe radiomics and deep learning models can well predict the malignancy of solid pulmonary nodules. Radiomics signatures also demonstrate prognostic value in solid adenocarcinomas.

Indexed as

AdenocarcinomaAdenocarcinoma of LungDeep LearningLung NeoplasmsHumansPrognosisRetrospective StudiesTomography, X-Ray ComputedAdenocarcinomaDeep learningDisease-free survivalRadiomicsSolid pulmonary nodules

Identifiers

PMID36319968
PMCPMC9628173
OpenAlexW4308015678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.